Skip to content

Haemonetics

US · HAE #2165 by market cap Listed 1970
120.16 -0.21 -0.17%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Recent news

  • Company notice
    Hae In: Report on significant holdings of stocks, etc. (General)
    OPENDART · 2026/8/24
  • J.P. Morgan Initiates Haemonetics(HAE.US) With Hold Rating, Announces Target Price $125
    Market Newswire · 2026/11/10
  • Company notice
    Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
    SEC · 2025/9/25
  • Rating change
    Baird Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $119
    Market Newswire · 2026/8/21
  • Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $140
    Market Newswire · 2026/10/26
  • Rating change
    Raymond James Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $125
    Market Newswire · 2026/9/3
  • A Quick Look at Today's Ratings for Haemonetics(HAE.US), With a Forecast Between $145 to $165
    Market Newswire · 2026/11/7
  • Rating change
    Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $118
    Market Newswire · 2026/10/1
  • Rating change
    Citi Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $123
    Market Newswire · 2026/9/18
  • Rating change
    BTIG Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $130
    Market Newswire · 2026/10/20
  • Company notice
    Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
    SEC · 2025/6/10
  • Company notice
    4: Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
    SEC · 2026/6/9
  • Rating change
    Mizuho Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $140
    Market Newswire · 2026/10/9
  • Rating change
    BTIG Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $130
    Market Newswire · 2026/10/8
  • Rating change
    Citi Upgrades Haemonetics(HAE.US) to Buy Rating, Raises Target Price to $123
    Market Newswire · 2026/9/17
  • Company notice
    Haemonetics | 4: Statement of changes in beneficial ownership of securities-Officer Miller Laurie A.
    SEC · 2026/5/20
  • Rating change
    BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $140
    Market Newswire · 2026/10/9
  • Rating change
    Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $140
    Market Newswire · 2026/10/9
  • Jefferies Initiates Haemonetics(HAE.US) With Buy Rating, Announces Target Price $150
    Market Newswire · 2026/11/13
  • Needham Maintains Haemonetics(HAE.US) With Hold Rating
    Market Newswire · 2026/10/22
  • Rating change
    Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $118
    Market Newswire · 2026/8/19
  • Rating change
    BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Raises Target Price to $120
    Market Newswire · 2026/8/18
  • Rating change
    BofA Securities Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $120
    Market Newswire · 2026/8/18
  • Rating change
    Needham Maintains Haemonetics(HAE.US) With Hold Rating
    Market Newswire · 2026/8/18
  • Rating change
    Citi Maintains Haemonetics(HAE.US) With Hold Rating, Maintains Target Price $92
    Market Newswire · 2026/8/13

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.

Haemonetics discussion 0 comments

Add a comment